Your browser doesn't support javascript.
loading
Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
Craig, Jeffrey W; Farinha, Pedro; Jiang, Aixiang; Lytle, Andrew; Skinnider, Brian; Slack, Graham W.
  • Craig JW; Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
  • Farinha P; Centre for Lymphoid Cancer and Laboratory Medicine, BC Cancer, Vancouver, Canada.
  • Jiang A; Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, Canada.
  • Lytle A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Skinnider B; Centre for Lymphoid Cancer and Laboratory Medicine, BC Cancer, Vancouver, Canada.
  • Slack GW; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Am J Clin Pathol ; 160(2): 114-118, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37526500
ABSTRACT

OBJECTIVES:

Multiple case reports describe Kikuchi-Fujimoto disease (KFD) following COVID-19 vaccination, but the true nature of this phenomenon is unknown. The purpose of this study was to further assess the relationship between KFD and COVID-19 vaccination at the population level.

METHODS:

Confirmed KFD cases from January 2018 to April 2022 were identified from provincial pathology archives and analyzed in the context of vaccination statistics from public health resources.

RESULTS:

Our statistical models provide evidence of a temporal association between KFD and both antecedent COVID-19 vaccine administration as well as age-stratified vaccination rates. Eight new cases of plausible COVID-19 vaccine-associated KFD are presented, collectively exhibiting clinical and pathologic features that overlap substantially with those of idiopathic KFD.

CONCLUSIONS:

Our findings indicate that KFD is observed in association with COVID-19 vaccination and suggest that mechanistic studies are warranted.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfadenitis Necrotizante Histiocítica / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfadenitis Necrotizante Histiocítica / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article